These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20970840)

  • 1. Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer.
    Kattan MW; Yu C; Salomon L; Vora K; Touijer K; Guillonneau B
    Urology; 2011 Feb; 77(2):396-401. PubMed ID: 20970840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
    Eskicorapci SY; Türkeri L; Karabulut E; Cal C; Akpinar H; Baltaci S; Baykal K; ; Kattan MW; Ozen H
    Urology; 2009 Dec; 74(6):1289-95. PubMed ID: 19589584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy.
    Talantov D; Jatkoe TA; Böhm M; Zhang Y; Ferguson AM; Stricker PD; Kattan MW; Sutherland RL; Kench JG; Wang Y; Henshall SM
    J Urol; 2010 Oct; 184(4):1521-8. PubMed ID: 20723930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
    Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
    BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
    Shariat SF; Park S; Trinh QD; Roehrborn CG; Slawin KM; Karakiewicz PI
    J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
    Shariat SF; Walz J; Roehrborn CG; Zlotta AR; Perrotte P; Suardi N; Saad F; Karakiewicz PI
    J Clin Oncol; 2008 Mar; 26(9):1526-31. PubMed ID: 18349404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
    Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
    BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer.
    Bauer JJ; Connelly RR; Seterhenn IA; Deausen J; Srivastava S; McLeod DG; Moul JW
    J Urol; 1998 Mar; 159(3):929-33. PubMed ID: 9474185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
    Isbarn H; Karakiewicz PI; Walz J; Ahyai SA; Steuber T; Haese A; Budäus L; Schlomm T; Eichelberg C; Heuer R; Heinzer H; Huland H; Graefen M; Chun FK
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):788-92. PubMed ID: 19818565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
    Graefen M; Augustin H; Karakiewicz PI; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino PT; Kattan MW; Huland H
    Urologe A; 2003 May; 42(5):685-92. PubMed ID: 12750804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.
    O'Brien BA; Cohen RJ; Wheeler TM; Moorin RE
    BJU Int; 2011 Feb; 107(3):389-95. PubMed ID: 20707795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
    BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
    Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
    J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.
    San Francisco IF; Regan MM; Olumi AF; DeWolf WC
    J Urol; 2004 Apr; 171(4):1492-9. PubMed ID: 15017206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.
    Thanigasalam R; Rasiah KK; Stricker PD; Haynes AM; Sutherland SI; Sutherland RL; Henshall SM; Horvath LG
    BJU Int; 2010 Mar; 105(5):642-7. PubMed ID: 19751263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.